Teva Stock Soars 19% as Game-Changing IBD Drug Duvakitug Crushes Trial Expectations - Yahoo Finance

Teva up 19%, Sanofi 4% after duvakitug's trial success stuns investors. and for good reasonAds Links by Easy Branches
Play online games for free at games.easybranches.com

Guest Post Services www.easybranches.com/contribute